Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “derivative”

1,342 pharma patents match "derivative" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,342
Index total 30,257
Page 3 / 56

Quick answer

This filtered view shows 1,342 pharmaceutical patents matching "derivative" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,342 results for “derivative” · 30,257 patents in full index Clear search

  1. US 12133856

    Multi-substituent psilocybin derivatives and methods of using

    Enveric Biosciences Canada Inc. · Granted Nov 5, 2024 · Expires Oct 31, 2044

    granted
  2. US 12129222

    Production of bitter principle derivatives

    Julius-Maximilians-Universitaet · Granted Oct 29, 2024 · Expires Oct 24, 2044

    granted
  3. US 12128058

    Multi-substituent psilocybin derivatives and methods of using

    Enveric Biosciences Canada Inc. · Granted Oct 29, 2024 · Expires Oct 24, 2044

    granted
  4. US 12116423

    Ang (1-7) derivative oligopeptides and methods for using and producing the same

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Oct 15, 2024 · Expires Oct 10, 2044

    granted
  5. US 12109198

    Macrocyclic azolopyridine derivatives as EED and PRC2 modulators

    Fulcrum Therapeutics, Inc. · Granted Oct 8, 2024 · Expires Oct 3, 2044

    granted
  6. US 12098138

    Substituted pyridinyl azetidinone derivatives for use in treating cancer and other diseases

    The Board of Regents of the University of Texas System · Granted Sep 24, 2024 · Expires Sep 19, 2044

    granted
  7. US 12091407

    Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof

    VTV THERAPEUTICS LLC · Granted Sep 17, 2024 · Expires Sep 12, 2044

    granted
  8. US 12084431

    Pharmaceutical salts of pyrimidine derivatives and method of treating disorders

    Takeda Pharmaceutical Company Limited · Granted Sep 10, 2024 · Expires Sep 5, 2044

    granted
  9. US 12077506

    Indane derivatives as hypoxia inducible factor-2(α) inhibitors

    NIKANG THERAPEUTICS, INC. · Granted Sep 3, 2024 · Expires Aug 29, 2044

    granted
  10. US 12077498

    C4-carboxylic acid-substituted tryptamine derivatives and methods of using

    Enveric Biosciences Canada Inc. · Granted Sep 3, 2024 · Expires Aug 29, 2044

    granted
  11. US 12071413

    Azole derivatives as apelin receptor agonist

    SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · Granted Aug 27, 2024 · Expires Aug 22, 2044

    granted
  12. US 12065404

    C4-carboxylic acid-substituted tryptamine derivatives and methods of using

    Enveric Biosciences Canada Inc. · Granted Aug 20, 2024 · Expires Aug 15, 2044

    granted
  13. US 12054474

    Sulfonyl piperidine derivatives and their use for treating prokineticin mediated diseases

    Takeda Pharmaceutical Company Limited · Granted Aug 6, 2024 · Expires Aug 1, 2044

    granted
  14. US 12042543

    Substituted 3-amino-5-phenylbenzamide compounds as covalent inhibitors of enhancer zeste homolog 2 (EZH2) and proteolysis-targeting chimeric derivatives thereof (PROTACs) that induce degradation of EZH2

    Northwestern University · Granted Jul 23, 2024 · Expires Jul 18, 2044

    granted
  15. US 12036211

    Nicorandil derivatives

    UNICYCIVE THERAPEUTICS, INC. · Granted Jul 16, 2024 · Expires Jul 11, 2044

    granted
  16. US 12030897

    Pyrrolo[2,1-f][1,2,4]triazine derivatives serving as selective HER2 inhibitors and application thereof

    Medshine Discovery Inc. · Granted Jul 9, 2024 · Expires Jul 4, 2044

    granted
  17. US 12018027

    Macrocyclic derivatives acting as XIa factor inhibitor

    China Resources Biopharmaceutical Company Limited · Granted Jun 25, 2024 · Expires Jun 20, 2044

    granted
  18. US 11999748

    Exatecan derivatives, linker-payloads, and conjugates and thereof

    GENEQUANTUM HEALTHCARE (SUZHOU) CO., LTD. · Granted Jun 4, 2024 · Expires May 30, 2044

    granted
  19. US 11998557

    Halogenated psilocybin derivatives and methods of using

    Enveric Biosciences Canada Inc. · Granted Jun 4, 2024 · Expires May 30, 2044

    granted
  20. US 11987586

    Pyrrolo[1,2-c]imidazole derivatives as orexin type 2 receptor agonists

    Takeda Pharmaceutical Company Limited · Granted May 21, 2024 · Expires May 16, 2044

    granted
  21. US 11981750

    Antigenic tripeptides derived from Mycobacterium avium subsp. paratuberculosis s-type strains, derivatives and uses thereof

    The United States of America, as represented by the Secretary of Agriculture · Granted May 14, 2024 · Expires May 9, 2044

    granted
  22. US 11981662

    Pyrazole derivatives with anticancer activity

    The Board of Regents of the University of Texas System · Granted May 14, 2024 · Expires May 9, 2044

    granted
  23. US 11970521

    Neuroprotective beta amyloid core peptides and peptidomimetic derivatives

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Apr 30, 2024 · Expires Apr 25, 2044

    granted
  24. US 11958879

    Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof

    Enanta Pharmaceuticals, Inc. · Granted Apr 16, 2024 · Expires Apr 11, 2044

    granted